Covid-19 Vaccine: The dose of Sputnik V, the first vaccine made in the world in the fight against Corona, is now available in more than 50 cities and towns of the country. This information has been given by Dr Reddy Laboratories today. Dr Reddy did a soft launch of this Russian vaccine on 14 May on 14 May. In a tweet made on Monday night, Dr Reddy’s said that this will strengthen the position of commercial launch of this vaccine in the coming weeks.
Companies launch their products in small numbers in the market before they are fully launched. This is done as a preparation before the product is fully launched, also known as soft launch. With this, companies get an advance idea of the problems or bottlenecks that may come after the launch and they are able to remove them easily. Generally, soft launches are not widely publicized. It can also be called a kind of rehearsal.
Mixing Covid-19 Vaccines: WHO warns about vaccine mixing, Chief Scientist calls it a dangerous trend
Russian vaccine soft launched in these cities
Dr Reddy’s first launched Sputnik V in Hyderabad but now it is available in many cities and towns across the country. According to the tweet issued by the company, the dosage of this vaccine is Hyderabad, Vizag, Bangalore, Mumbai, Navi Mumbai, Kolkata, Delhi NCR, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik, Coimbatore, Ranchi, Jaipur, Lucknow, Patna, Bhubaneswar, Guwahati, Thiruvananthapuram, Ahmedabad, Rajkot, Palakkad, Allahabad, Dimapur, Kohima, Indore, Bhopal, Surat, Cuttack, Dharwad, Ernakulam, Ratlam, Faridabad, Srinagar, Gandhinagar, Vadodara, Gulbarga, Available in Madurai, Guntur, Kannur, Jabalpur, Jalandhar, Kanpur and Mysore. The company has partnered with many major hospitals of the country for vaccination.
Partnership for 12.5 crore doses
Recently, Dr Reddy’s received about 30 lakh doses of Sputnik V from the Russian Director’s Investment Fund (RDIF). Dr Reddy’s has partnered with RDIF for 12.5 crore people doses (25 crore voices) in India. Indian drug regulator DGCI has given approval for restricted emergency use of Russian vaccine. This vaccine has been developed by the Gamelaya National Research Institute of Epidemiology and Microbiology.